Safety of Intravenous Iron in CKD Stage 3-5 Patients Not on Dialysis: A Retrospective Cohort Study.

ABSTRACT:

Background

Iron deficiency is common in chronic kidney disease (CKD) patients not on dialysis (ND). Restoring depleted iron stores through intravenous (IV) route is faster and associated with less side effects. There is conflicting data regarding intravenous iron use and its impact on clinical outcomes in this population.

Objective

This study aims at evaluating any negative clinical impact associated with IV iron use in CKD patients at stages (3-5) before dialysis.

Design

Retrospective chart review.

Setting and population

Chart analysis of ND CKD 3-5 (estimated glomerular filtration rate [eGFR] <60 mL/min/1.73 m²) patients who received IV iron between January 2013 and January 2018 in 3 major hospitals in Kuwait.

Methods

Outcomes analyzed were

SUBMITTER: AlSahow A 

PROVIDER: S-EPMC9619264 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature